Founded in 2011, based out of Vancouver, BC, Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to currently approved drugs. Each of Eupraxia's product candidates has the potential to address therapeutic areas with high unmet medical need, and strives to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects.
View Top Employees from Eupraxia Pharmaceuticals Inc| Website | http://www.eupraxiapharma.com |
| Ticker | EPRX |
| Revenue | $10 million |
| Employees | View employees |
| Founded | 2012 |
| Address | 2067 Cadboro Bay Rd, #201, Victoria, British Columbia V8R 5G4, CA |
| Phone | (250) 590-3968 |
| Fax | (250) 590-2588 |
| Industry | Biotechnology, Pharmaceuticals, Drug Delivery, Science and Engineering, Healthcare, Medical, Health Care, Pharmaceutical |
| Competitors | Augurex Life Sciences Corp., Aurinia Pharmaceuticals Inc., Envisia Therapeutics, Msi Methylation Sciences INC, Sirona Biochem Corp. |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Eupraxia Pharmaceuticals Inc employee's phone or email?
Eupraxia Pharmaceuticals Inc Questions
The Eupraxia Pharmaceuticals Inc annual revenue was $10 million in 2023.
Eupraxia Pharmaceuticals Inc is based in Victoria, British Columbia.
The NAICS codes for Eupraxia Pharmaceuticals Inc are [32, 32541, 325, 3254].
The SIC codes for Eupraxia Pharmaceuticals Inc are [28, 283].
